Elvitegravir Sirolimus 269

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Clinical Effects

Increased sirolimus adverse effects (increased immunosuppression)

Management

If coadministering, initiate lower dose of immunosuppressant, therapeutic drug monitoring is recommended, assess toxicity, consult with specialist, and adjust dose as necessary

Import ID
269